annual Report 2009 - STRATEC Biomedical AG

More documents

Recommendations

Info

The Share 2009 on the stock markets The international financial crisis, which had its roots in the US real estate crisis in mid-2007, increasingly spilled over onto the real economy in 2008 and 2009. Having said this, the 2009 trading year nevertheless took a surprising turn for many market players. Until early March 2009, stock markets were faced with doomsday scenarios. The global financial system was on the brink of collapse and the 200 economy threatened to slide into a period of depression. Only robust, coordinated intervention by the governments of leading industrialized nations and their central banks prevented a collapse. Industrial output showed double-digit year-on-year declines in many countries, gross domestic 150 product fell at a rate rarely seen in the past, unemployment rose sharply. In short, at the beginning of 2009 the global economy was in the grip of one of its severest crises in recent times. 100 From March 2009, positive news from the banking sector and significant improvements in early economic indicators led to a turnaround on the stock markets. The economy then actually followed the path forecast in these early indicators. In the third quarter of 2009, gross domestic product in the 50US, for example, showed marked growth once again compared with the previous quarter. The increasingly favorable climate on the stock markets from March onwards ultimately enabled the DAX to close the year 23.3 % up on the previous year. The TecDAX index rose by 60.8 %. STRATEC’s share performance Starting at u 13.55 (XETRA, closing price on December 30, 2008), STRATEC’s share was unable to escape the overall trend in the sector, initially losing dispropor tionate ground compared, for example, with German medical technology indices (benchmark, see share performance chart). STRATEC’s share reached its annual low at u 8.00 on March 6, 2009 (XETRA, intraday). The publication of pleasing company news and improved stock market climate then enabled STRATEC’s share to clearly outperform its benchmark and, apart from a temporary period of weakness in June 2009, to rise consistently to its annual high of u 28.14 on December 15, 2009 (XETRA, intraday). STRATEC’s share closed at u 26.58 on December 30, 2009, thus ending an eventful and highly volatile year on the market 96.2 % up on the previous year. Performance comparison of STRATEC’s share (indexed, January 2009 to December 2009) in % 200 200 STRATEC’s share ISIN: DE0007289001 DAXsubsector Medical Technology Index ISIN: DE0007238024 DAXsector Pharma & Healthcare Index ISIN: DE0009660324 150 150 100 100 50 50 Jan Feb Mar Apr May June July Aug Sep Oct Nov Dec Jan Feb 2009 2010 18 stratec Annual Report 2009
Report of the board of Management Report of the supervisory board THE share Corporate Governance Group Management report Consolidated financial statements Service Key figures for STRATEC’s share 2009 2008 2007 2006 2005 Year-end price previous year in u 13.55 20.75 22.00 14.93 5.68 Annual low in u 8.00 10.56 17.16 11.44 5.44 Annual high in u 28.14 22.00 29.53 22.50 15.66 Year-end price in u 26.58 13.55 20.75 22.00 14.93 Year-on-year performance comparison in u +13.03 -7.20 -1.25 +7.07 +9.25 Year-on-year performance comparison in % +96.2 -34.7 -5.7 +47.4 +162.9 Share capital in u million 11.4 11.4 11.4 11.3 11.0 Number of shares in millions 11.4 11.4 11.4 11.3 11.0 Market capitalization (total) in u million 304.2 154.8 236.9 247.7 163.6 Trading volumes * in u million 61.9 104.6 176.0 135.7 90.8 Average volume per trading day * numbers 12,937 26,597 30,641 18,593 11,453 Average volume per trading day * in u 243,383 411,813 698,570 532,111 353,447 * trading volumes of STRATEC shares across all German marketplaces Share capital A total of 14,487 stock option rights were exercised in the 2009 financial year within the stock option programs introduced for managers and employees. The 20,042 new shares arising as a result increased the share capital by u 20,042. The share capital amounted to u 11,445,736 as of December 31, 2009, and was divided into 11,445,736 ordinary bearer shares. These shares are evidenced in global notes. The Articles of Association exclude any claims on the part of shareholders to the certification of their shares. Pursuant to § 15 No. 15.3. of the Articles of Association of STRATEC AG, each share entitles its bearer to one vote. stratec Annual Report 2009 19
Page 1 and 2: 2009 Annual Report
Page 3 and 4: Key figures at a glance and Locatio
Page 5 and 6: committed to quality proven partner
Page 7 and 8: Report of the board of Management R
Page 13 and 14: 6:50 7:30 7.00 a.m. Getting ready t
Page 15 and 16: 10:38 11:40 8.38 a.m. Talking to th
Page 17 and 18: 3:08 4:12 1.55 p.m. Analyzing the b
Page 19 and 20: 6:55 7:25 4.20 p.m. Getting the res
Page 21: 10:08 10:20 Just one example of wha
Page 73 and 74:
Report of the board of Management R
Page 75 and 76:
Page 77 and 78:
Page 79 and 80:
Page 81 and 82:
Page 83 and 84:
Page 85 and 86:
Page 87 and 88:
Page 89 and 90:
Page 91 and 92:
Page 93 and 94:
Page 95 and 96:
Page 97 and 98:
Page 99 and 100:
Page 101 and 102:
Page 103 and 104:
Page 105 and 106:
Page 107 and 108:
Page 109 and 110:
Page 111 and 112:
Page 113 and 114:
Page 115 and 116:
Page 117 and 118:
Page 119 and 120:
show all

annual Report 2009 - STRATEC Biomedical AG

Create successful ePaper yourself

Delete template?

Save as template?